Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 INHIBITION OF THE C'-1 COMPONENT OF COMPLEMENT BY AMINO ACIDS.

× No keyword cloud information.

12 in total

1. IDENTIFICATION OF THE COMPONENTS OF COMPLEMENT PARTICIPATING IN THE ANTIGLOBULIN REACTION.

Authors: M HARBOE; H J MUELLER-EBERHARD; H FUDENBERG; M J POLLY; P L MOLLISON
Journal: Immunology Date: 1963-07 Impact factor: 7.397

2. xi-Aminocaproic acid: an inhibitor of plasminogen activation.

Authors: N ALKJAERSIG; A P FLETCHER; S SHERRY
Journal: J Biol Chem Date: 1959-04 Impact factor: 5.157

3. TAMe esterase activity of guinea-pig serum. II. Peptone inducible esterases.

Authors: E L BECKER; K F AUSTEN; D M MARCUS
Journal: Br J Exp Pathol Date: 1959-10

4. Effect of acid polysaccharides on the fibrinolytic system in guinea-pig serum.

Authors: E S OLESEN
Journal: Acta Pharmacol Toxicol (Copenh) Date: 1959

5. Concerning the mechanism of complement action. II. The nature of the first component of guinea pig complement.

Authors: E L BECKER
Journal: J Immunol Date: 1956-12 Impact factor: 5.422

6. Concerning the mechanism of complement action. I. Inhibition of complement activity by diisopropyl fluophosphate.

Authors: E L BECKER
Journal: J Immunol Date: 1956-12 Impact factor: 5.422

7. THE OSMOTIC RESISTANCE (FRAGILITY) OF HUMAN RED CELLS.

Authors: A K Parpart; P B Lorenz; E R Parpart; J R Gregg; A M Chase
Journal: J Clin Invest Date: 1947-07 Impact factor: 14.808

8. Interaction of a serum inhibitor of C'I-esterase with intermediate complexes of the immune haemolytic system. I. Specificity of inhibition of C'I activity associated with intermediate complexes.

Authors: I H LEPOW; M A LEON
Journal: Immunology Date: 1962-03 Impact factor: 7.397

9. Some effects of proteolytic inhibitors on tissue injury and systemic anaphylaxis.

Authors: B W ZWEIFACH; A L NAGLER; W TROLL
Journal: J Exp Med Date: 1961-02-01 Impact factor: 14.307

10. Specificity of the reaction between rheumatoid factors and gamma globulin.

Authors: H H FUDENBERG; H G KUNKEL
Journal: J Exp Med Date: 1961-08-01 Impact factor: 14.307

10 in total

1. Production of histamine-like and prostaglandin-like substances from serum incubated with rat, dog, mouse or human tumours.

Authors: M C Apps; D B Cater
Journal: Br J Exp Pathol Date: 1973-04

2. Conversion of the fourth complement component studied by crossed immunoelectrophoresis.

Authors: A G Sjöholm; A B Laurell
Journal: Clin Exp Immunol Date: 1973-08 Impact factor: 4.330

3. A case of hereditary angioneurotic oedema, successfully treated with epsilon-aminocaproic acid. Studies on C'1 esterase inhibitor, C'1 activation, plasminogen level and histamine metabolism.

Authors: B Lundh; A B Laurell; H Wetterqvist; T White; G Granerus
Journal: Clin Exp Immunol Date: 1968-09 Impact factor: 4.330

4. Inhibition of the classical and alternative pathways by amino acids and their derivatives.

Authors: Y Takada; Y Arimoto; H Mineda; A Takada
Journal: Immunology Date: 1978-03 Impact factor: 7.397

5. The influence of epsilon-aminocaproic acid and related compounds on antigen-antibody reactions.

Authors: W Auerswald; W Doleschel
Journal: Br J Exp Pathol Date: 1966-10

6. In vitro inhibition of the classical and alternate pathways of activation of human complement by N acetyl aspartyl glutamic acid (NAAGA).

Authors: M Etievant; B Leluc; B David
Journal: Agents Actions Date: 1988-06

7. Permeability-increasing activity in hereditary angioneurotic edema plasma. II. Mechanism of formation and partial characterization.

Authors: V H Donaldson; O D Ratnoff; W Dias Da Silva; F S Rosen
Journal: J Clin Invest Date: 1969-04 Impact factor: 14.808

INHIBITION OF THE C'-1 COMPONENT OF COMPLEMENT BY AMINO ACIDS.